Louis Lassalle1, R Campagna2, G Corcos2, A Babinet3, F Larousserie4, J Stephanazzi5, A Feydy2. 1. Service de radiologie ostéo-articulaire, Hopital Cochin-APHP Paris Université Paris Descartes, Paris, France. louis.lassalle@gmail.com. 2. Service de radiologie ostéo-articulaire, Hopital Cochin-APHP Paris Université Paris Descartes, Paris, France. 3. Service de chirurgie orthopédique, Hopital Cochin-APHP Paris Université Paris Descartes, Paris, France. 4. Service d'anatomo-pathologie, Hopital Cochin-APHP Paris Université Paris Descartes, Paris, France. 5. Service d'anesthésie, Hopital Cochin-APHP Paris Université Paris Descartes, Paris, France.
Abstract
OBJECTIVE: To assess the long-term outcome of computed tomography-guided radiofrequency ablation (CT-guided RFA) in patients with suspected osteoid osteoma (OO). MATERIALS AND METHODS: Single-center retrospective study. Patients with clinical suspicion and imaging diagnosis of osteoid osteoma were treated by CT-guided RFA using the same device with either a 7- or 10-mm active tip electrode. Specific precautions were applied in case of articular or spinal OO. Patients were contacted by phone to evaluate the long-term outcome in terms of pain, ability to perform daily activities (including sports), and long-term complications. Success was defined as the absence of residual pain and ability to perform daily activities normally. RESULTS: From 2008 to 2015, 126 patients were treated by CT-guided RFA for OO in our institution. Mean patient age was 26.1 years (SD = 11, range 1-53); mean delay to diagnosis was 16.9 months (SD = 15.2, range 1-120). Among patients who answered the follow-up call (n = 88), the overall success rate was 94.3%: 79/88 (89.8%) had primary success of the procedure, and 4/88 (4.5%) had a secondary success (repeat-RFA after pain recurrence). Mean follow-up time was 34.6 months (SD = 24.7, range 3-90). Few complications occurred: two mild reversible peripheral nerve injuries, one brachial plexus neuropathy, one broken electrode tip fragment, and one muscular hematoma. CONCLUSION: Osteoid osteoma can be effectively and safely treated by CT-guided RFA using the presented ablation protocol. Beneficial effects of the treatment persist at long-term follow-up.
OBJECTIVE: To assess the long-term outcome of computed tomography-guided radiofrequency ablation (CT-guided RFA) in patients with suspected osteoid osteoma (OO). MATERIALS AND METHODS: Single-center retrospective study. Patients with clinical suspicion and imaging diagnosis of osteoid osteoma were treated by CT-guided RFA using the same device with either a 7- or 10-mm active tip electrode. Specific precautions were applied in case of articular or spinal OO. Patients were contacted by phone to evaluate the long-term outcome in terms of pain, ability to perform daily activities (including sports), and long-term complications. Success was defined as the absence of residual pain and ability to perform daily activities normally. RESULTS: From 2008 to 2015, 126 patients were treated by CT-guided RFA for OO in our institution. Mean patient age was 26.1 years (SD = 11, range 1-53); mean delay to diagnosis was 16.9 months (SD = 15.2, range 1-120). Among patients who answered the follow-up call (n = 88), the overall success rate was 94.3%: 79/88 (89.8%) had primary success of the procedure, and 4/88 (4.5%) had a secondary success (repeat-RFA after pain recurrence). Mean follow-up time was 34.6 months (SD = 24.7, range 3-90). Few complications occurred: two mild reversible peripheral nerve injuries, one brachial plexus neuropathy, one broken electrode tip fragment, and one muscular hematoma. CONCLUSION:Osteoid osteoma can be effectively and safely treated by CT-guided RFA using the presented ablation protocol. Beneficial effects of the treatment persist at long-term follow-up.
Authors: Christoph Rehnitz; Simon David Sprengel; Burkhard Lehner; Karl Ludwig; Georg Omlor; Christian Merle; Hans-Ulrich Kauczor; Volker Ewerbeck; Marc-André Weber Journal: Eur J Radiol Date: 2012-07-06 Impact factor: 3.528
Authors: Ralf-Thorsten Hoffmann; Tobias F Jakobs; Constanze H Kubisch; Christoph G Trumm; Christof Weber; Hans-Roland Duerr; Thomas K Helmberger; Maximilian F Reiser Journal: Eur J Radiol Date: 2009-01-13 Impact factor: 3.528
Authors: D I Rosenthal; F J Hornicek; M W Wolfe; L C Jennings; M C Gebhardt; H J Mankin Journal: J Bone Joint Surg Am Date: 1998-06 Impact factor: 5.284